324
Views
33
CrossRef citations to date
0
Altmetric
Chemerin and PCOS

Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome

, , &
Pages 152-155 | Received 10 Jun 2014, Accepted 19 Sep 2014, Published online: 08 Oct 2014

References

  • Goodarzi MO, Dumesic DA, Chazenbalk G and Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219–31
  • Carmina E, Bucchieri S and Mansueto Pet al. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertil Steril 2009;91:1332–5
  • Carmina E, Orio F and Palomba Set al. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol/Eur Fed Endocr Soc 2005;152:389–94
  • Vardhana PA, Dicken C and Tortoriello DVet al. Increasing adiposity in normal ovulatory women affects adipocytokine expression in subcutaneous and visceral abdominal fat. Int J Gynaecol Obstet: Off Organ Int Fed Gynaecol Obstet 2009;104:121–4
  • Chen X, Jia X and Qiao Jet al. Adipokines in reproductive function: a link between obesity and polycystic ovary syndrome. J Mol Endocrinol 2013;50:R21–37
  • Carmina E, Chu C and Moran Cet al. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome. Fertil Steril 2008;89:642–8
  • Guzel EC, Celik C, Abali R, et al. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome. Gynecol Endocrinol: Off J Int Soc Gynecol Endocrinol 2014;30:419–22
  • Chu SH, Lee MK and Ahn KYet al. Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PloS One 2012;7:e34710
  • Mahde A, Shaker M and Al-Mashhadani Z. Study of omentin 1 and other adipokines and hormones in PCOS patients. Oman Med J 2009;24:108–18
  • Choi JH, Rhee EJ and Kim KHet al. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome. Eur J Endocrinol/Eur Fed Endocr Soc 2011;165:789–96
  • Jialal I, Devaraj S and Kaur Het al. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metabol 2013;98:E514–17
  • Bozaoglu K, Bolton K and McMillan Jet al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007;148:4687–94
  • Lee MK, Chu SH and Lee DCet al. The association between chemerin and homeostasis assessment of insulin resistance at baseline and after weight reduction via lifestyle modifications in young obese adults. Clin Chim Acta 2013;421:109–15
  • Stefanov T, Bluher M and Vekova Aet al. Circulating chemerin decreases in response to a combined strength and endurance training. Endocrine 2014;45:382–91
  • Jacobs HS and Conway GS. Leptin, polycystic ovaries and polycystic ovary syndrome. Hum Reprod Update 1999;5:166–71
  • Tan BK, Chen J and Farhatullah Set al. Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 2009;58:1971–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.